Skip to main content
Innoviva, Inc. logo

Innoviva, Inc. — Investor Relations & Filings

Ticker · INVA ISIN · US45781M1018 LEI · 549300ACOX4QTBES6535 US Financial and insurance activities
Open in API
Filings indexed 1,226 across all filing types
Latest filing 2011-05-04 Interim / Quarterly Rep…
Country US United States of America
Listing US INVA

About Innoviva, Inc.

https://www.inva.com/

Innoviva, Inc. is a diversified holding company that manages a portfolio of royalty-generating assets and operates a commercial-stage biopharmaceutical platform. The company's core royalty business is centered on respiratory therapies, providing a stable cash flow. Through its subsidiary, Innoviva Specialty Therapeutics, it focuses on developing and commercializing innovative treatments for patients in critical care and with infectious diseases. Innoviva's strategy involves leveraging its financial assets to invest in healthcare opportunities with high unmet medical needs, aiming to advance differentiated therapies and build a diverse portfolio of healthcare assets.

Recent filings

Filing Released Lang Actions
10-Q Filing
Interim / Quarterly Report Q1 2011
2011-05-04 English
S-8 Filing
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by Theravance, Inc. on May 4, 2011. It relates to the registration of securities under the Securities Act of 1933, specifically for the 2004 Employee Stock Purchase Plan. The document includes details about the securities to be registered, indemnification of directors and officers, incorporation by reference of other SEC filings, and exhibits related to corporate governance documents. It is not a financial report, earnings release, or management discussion, but rather a regulatory filing for securities registration. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings that do not fit other specific categories.
2011-05-04 English
8-K Filing
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 27, 2011, reporting the submission of matters to a vote of security holders at the Annual Meeting of Stockholders. It details the voting results for director elections, approval of an amendment to the Employee Stock Purchase Plan, advisory votes on executive compensation, and ratification of the independent auditor. The content is focused on official voting results from a shareholder meeting, not the meeting materials or the meeting itself. The document length is 4273 characters, which is relatively short but contains detailed voting results. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)' which covers official results from shareholder votes at any general meeting. Therefore, the correct classification is DVA with high confidence.
2011-05-02 English
4 Filing
Director's Dealing
2011-04-28 English
4 Filing
Director's Dealing
2011-04-28 English
4 Filing
Director's Dealing
2011-04-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.